Two PCs—PC1 and PC4—increased OTC protein stability and activity in control hiPSC‐Heps, while PC4 in addition increased OTC activity in patient‐derived PHHs from a female OTCD patient with unfavorable XCI. This evidence concerns the gene OTC and ornithine carbamoyltransferase deficiency.